Replies to post #17492 on Kiwa Bio-Tech Products Group Corp (fka KWBT)

[Hymeeto]

I am not sure either, I do not believe there is that much to dilute.... Just my opinion!

[dinogreeves]

Here you go.



Preliminary findings...

There are 7 notes. They are explained (disclosed terms). I believe most of them have these terms...
Quote:
70% of the lowest trading price during the 20 trading day period prior to the date of any notice of conversion.
...so for brevity, right now, I will take the total convertible notes outstanding AS OF September 30, 2019 and divide that total by 70% of the lowest trading price past 20 days and come up with a convert strike point of...$0.018 lowest trading price...70% of equals strike convert price at $0.0126 resulting in...$2,352,977 / $0.0126 = 186,744,206 shares...

[Suppressed Image]

Link > https://www.sec.gov/Archives/edgar/data/1159275/000149315219017301/form10-q.htm
Quote:
As of November 14, 2019, the Company had 23,738,781 shares of common stock, $0.001 par value, issued and outstanding.
I believe I saw that the current OSW was around 170 million? So, approximately 150 million diluted?

186,744,206 - 150,000,000 (added to OS since OS was 23,738,781 on November 14, 2109)...maybe 36 million to go?

Should be getting close to done on the convertibles.

I'll get back to you on this. Give you more accurate, detailed calculations...on each individual note...

[dinogreeves]

Here is another one for you. Evidently OTC update is marching towards 185-190 million by the time all dilution is done.


It is not my estimate, it is explained here in black and white.

https://investorshub.advfn.com/uimage/uploads/2020/2/2/bdaii0_-_kwbt_Convertible_Notes_Payable.png